aluates Reports

$ 0.0

Automative

Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-26A42

Global Radiopharmaceutical Market Insights and Forecast to 2028

BUY CHAPTERS

Radiopharmaceutical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-26A42

Report

August 2025

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bracco Imaging

Bayer

Lantheus

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Siemens

Siemens AG

Dongcheng

Cardinal Health

Novartis

Curium Pharma

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

Radiopharmaceutical- Market Size

The global market for Radiopharmaceutical was estimated to be worth US$ 6678 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.

Radiopharmaceutical- Market

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Radiopharmaceutical by region & country, by Type, and by Application.

The Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical.

Market Segmentation

Scope of Radiopharmaceutical- Market Report

Report Metric	Details
Report Name	Radiopharmaceutical- Market
Forecasted market size in 2031	US$ 10850 million
CAGR	7.3%
Forecasted years	2025 - 2031
Segment by Type	Diagnostic Radiopharmaceuticals Therapeutic Radiopharmaceuticals
Segment by Application	Oncology Cardiology Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Radiopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Radiopharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Radiopharmaceutical- Market size in 2031?

Ans: The Radiopharmaceutical- Market size in 2031 will be US$ 10850 million.

Who are the main players in the Radiopharmaceutical- Market report?

Ans: The main players in the Radiopharmaceutical- Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the Radiopharmaceutical- Market report?

Ans: The Applications covered in the Radiopharmaceutical- Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Radiopharmaceutical- Market report?

Ans: The Types covered in the Radiopharmaceutical- Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

1 Market Overview

1.1 Radiopharmaceutical Product Introduction

1.2 Global Radiopharmaceutical Market Size Forecast

1.2.1 Global Radiopharmaceutical Sales Value (2020-2031)

1.2.2 Global Radiopharmaceutical Sales Volume (2020-2031)

1.2.3 Global Radiopharmaceutical Sales Price (2020-2031)

1.3 Radiopharmaceutical Market Trends & Drivers

1.3.1 Radiopharmaceutical Industry Trends

1.3.2 Radiopharmaceutical Market Drivers & Opportunity

1.3.3 Radiopharmaceutical Market Challenges

1.3.4 Radiopharmaceutical Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Radiopharmaceutical Players Revenue Ranking (2024)

2.2 Global Radiopharmaceutical Revenue by Company (2020-2025)

2.3 Global Radiopharmaceutical Players Sales Volume Ranking (2024)

2.4 Global Radiopharmaceutical Sales Volume by Company Players (2020-2025)

2.5 Global Radiopharmaceutical Average Price by Company (2020-2025)

2.6 Key Manufacturers Radiopharmaceutical Manufacturing Base and Headquarters

2.7 Key Manufacturers Radiopharmaceutical Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical

2.9 Radiopharmaceutical Market Competitive Analysis

2.9.1 Radiopharmaceutical Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Diagnostic Radiopharmaceuticals

3.1.2 Therapeutic Radiopharmaceuticals

3.2 Global Radiopharmaceutical Sales Value by Type

3.2.1 Global Radiopharmaceutical Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Radiopharmaceutical Sales Value, by Type (2020-2031)

3.2.3 Global Radiopharmaceutical Sales Value, by Type (%) (2020-2031)

3.3 Global Radiopharmaceutical Sales Volume by Type

3.3.1 Global Radiopharmaceutical Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Radiopharmaceutical Sales Volume, by Type (2020-2031)

3.3.3 Global Radiopharmaceutical Sales Volume, by Type (%) (2020-2031)

3.4 Global Radiopharmaceutical Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oncology

4.1.2 Cardiology

4.1.3 Other

4.2 Global Radiopharmaceutical Sales Value by Application

4.2.1 Global Radiopharmaceutical Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Radiopharmaceutical Sales Value, by Application (2020-2031)

4.2.3 Global Radiopharmaceutical Sales Value, by Application (%) (2020-2031)

4.3 Global Radiopharmaceutical Sales Volume by Application

4.3.1 Global Radiopharmaceutical Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Radiopharmaceutical Sales Volume, by Application (2020-2031)

4.3.3 Global Radiopharmaceutical Sales Volume, by Application (%) (2020-2031)

4.4 Global Radiopharmaceutical Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Radiopharmaceutical Sales Value by Region

5.1.1 Global Radiopharmaceutical Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Radiopharmaceutical Sales Value by Region (2020-2025)

5.1.3 Global Radiopharmaceutical Sales Value by Region (2026-2031)

5.1.4 Global Radiopharmaceutical Sales Value by Region (%), (2020-2031)

5.2 Global Radiopharmaceutical Sales Volume by Region

5.2.1 Global Radiopharmaceutical Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Radiopharmaceutical Sales Volume by Region (2020-2025)

5.2.3 Global Radiopharmaceutical Sales Volume by Region (2026-2031)

5.2.4 Global Radiopharmaceutical Sales Volume by Region (%), (2020-2031)

5.3 Global Radiopharmaceutical Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Radiopharmaceutical Sales Value, 2020-2031

5.4.2 North America Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Radiopharmaceutical Sales Value, 2020-2031

5.5.2 Europe Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Radiopharmaceutical Sales Value, 2020-2031

5.6.2 Asia Pacific Radiopharmaceutical Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Radiopharmaceutical Sales Value, 2020-2031

5.7.2 South America Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Radiopharmaceutical Sales Value, 2020-2031

5.8.2 Middle East & Africa Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Radiopharmaceutical Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Radiopharmaceutical Sales Value

6.2.1 Key Countries/Regions Radiopharmaceutical Sales Value, 2020-2031

6.2.2 Key Countries/Regions Radiopharmaceutical Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Radiopharmaceutical Sales Value, 2020-2031

6.3.2 United States Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Radiopharmaceutical Sales Value, 2020-2031

6.4.2 Europe Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Radiopharmaceutical Sales Value, 2020-2031

6.5.2 China Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.5.3 China Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Radiopharmaceutical Sales Value, 2020-2031

6.6.2 Japan Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Radiopharmaceutical Sales Value, 2020-2031

6.7.2 South Korea Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Radiopharmaceutical Sales Value, 2020-2031

6.8.2 Southeast Asia Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Radiopharmaceutical Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Radiopharmaceutical Sales Value, 2020-2031

6.9.2 India Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

6.9.3 India Radiopharmaceutical Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Cardinal Health

7.1.1 Cardinal Health Company Information

7.1.2 Cardinal Health Introduction and Business Overview

7.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Cardinal Health Radiopharmaceutical Product Offerings

7.1.5 Cardinal Health Recent Development

7.2 GE Healthcare

7.2.1 GE Healthcare Company Information

7.2.2 GE Healthcare Introduction and Business Overview

7.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 GE Healthcare Radiopharmaceutical Product Offerings

7.2.5 GE Healthcare Recent Development

7.3 Jubilant Pharma

7.3.1 Jubilant Pharma Company Information

7.3.2 Jubilant Pharma Introduction and Business Overview

7.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Jubilant Pharma Radiopharmaceutical Product Offerings

7.3.5 Jubilant Pharma Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Introduction and Business Overview

7.4.3 Novartis Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Novartis Radiopharmaceutical Product Offerings

7.4.5 Novartis Recent Development

7.5 Curium Pharma

7.5.1 Curium Pharma Company Information

7.5.2 Curium Pharma Introduction and Business Overview

7.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Curium Pharma Radiopharmaceutical Product Offerings

7.5.5 Curium Pharma Recent Development

7.6 SIEMENS

7.6.1 SIEMENS Company Information

7.6.2 SIEMENS Introduction and Business Overview

7.6.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 SIEMENS Radiopharmaceutical Product Offerings

7.6.5 SIEMENS Recent Development

7.7 Lantheus

7.7.1 Lantheus Company Information

7.7.2 Lantheus Introduction and Business Overview

7.7.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Lantheus Radiopharmaceutical Product Offerings

7.7.5 Lantheus Recent Development

7.8 Bracco Imaging

7.8.1 Bracco Imaging Company Information

7.8.2 Bracco Imaging Introduction and Business Overview

7.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Bracco Imaging Radiopharmaceutical Product Offerings

7.8.5 Bracco Imaging Recent Development

7.9 Bayer

7.9.1 Bayer Company Information

7.9.2 Bayer Introduction and Business Overview

7.9.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Bayer Radiopharmaceutical Product Offerings

7.9.5 Bayer Recent Development

7.10 Eli Lilly

7.10.1 Eli Lilly Company Information

7.10.2 Eli Lilly Introduction and Business Overview

7.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Eli Lilly Radiopharmaceutical Product Offerings

7.10.5 Eli Lilly Recent Development

7.11 Aurobindo Pharma

7.11.1 Aurobindo Pharma Company Information

7.11.2 Aurobindo Pharma Introduction and Business Overview

7.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Aurobindo Pharma Radiopharmaceutical Product Offerings

7.11.5 Aurobindo Pharma Recent Development

7.12 Mundipharma

7.12.1 Mundipharma Company Information

7.12.2 Mundipharma Introduction and Business Overview

7.12.3 Mundipharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Mundipharma Radiopharmaceutical Product Offerings

7.12.5 Mundipharma Recent Development

7.13 China Isotope & Radiation

7.13.1 China Isotope & Radiation Company Information

7.13.2 China Isotope & Radiation Introduction and Business Overview

7.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 China Isotope & Radiation Radiopharmaceutical Product Offerings

7.13.5 China Isotope & Radiation Recent Development

7.14 Dongcheng

7.14.1 Dongcheng Company Information

7.14.2 Dongcheng Introduction and Business Overview

7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Dongcheng Radiopharmaceutical Product Offerings

7.14.5 Dongcheng Recent Development

8 Industry Chain Analysis

8.1 Radiopharmaceutical Industrial Chain

8.2 Radiopharmaceutical Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Radiopharmaceutical Sales Model

8.5.2 Sales Channel

8.5.3 Radiopharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bracco Imaging

Bayer

Lantheus

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Siemens

Siemens AG

Dongcheng

Cardinal Health

Novartis

Curium Pharma

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

List of Tables

Table 1. Radiopharmaceutical Market Trends

Table 2. Radiopharmaceutical Market Drivers & Opportunity

Table 3. Radiopharmaceutical Market Challenges

Table 4. Radiopharmaceutical Market Restraints

Table 5. Global Radiopharmaceutical Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Radiopharmaceutical Revenue Market Share by Company (2020-2025)

Table 7. Global Radiopharmaceutical Sales Volume by Company (2020-2025) & (K Dose)

Table 8. Global Radiopharmaceutical Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Radiopharmaceutical Price by Company (2020-2025) & (USD/Dose)

Table 10. Key Manufacturers Radiopharmaceutical Manufacturing Base and Headquarters

Table 11. Key Manufacturers Radiopharmaceutical Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical

Table 13. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Radiopharmaceutical Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Radiopharmaceutical Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Radiopharmaceutical Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Radiopharmaceutical Sales Market Share in Value by Type (2020-2025)

Table 20. Global Radiopharmaceutical Sales Market Share in Value by Type (2026-2031)

Table 21. Global Radiopharmaceutical Sales Volume by Type: 2020 VS 2024 VS 2031 (K Dose)

Table 22. Global Radiopharmaceutical Sales Volume by Type (2020-2025) & (K Dose)

Table 23. Global Radiopharmaceutical Sales Volume by Type (2026-2031) & (K Dose)

Table 24. Global Radiopharmaceutical Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Radiopharmaceutical Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Radiopharmaceutical Price by Type (2020-2025) & (USD/Dose)

Table 27. Global Radiopharmaceutical Price by Type (2026-2031) & (USD/Dose)

Table 28. Global Radiopharmaceutical Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Radiopharmaceutical Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Radiopharmaceutical Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Radiopharmaceutical Sales Market Share in Value by Application (2020-2025)

Table 32. Global Radiopharmaceutical Sales Market Share in Value by Application (2026-2031)

Table 33. Global Radiopharmaceutical Sales Volume by Application: 2020 VS 2024 VS 2031 (K Dose)

Table 34. Global Radiopharmaceutical Sales Volume by Application (2020-2025) & (K Dose)

Table 35. Global Radiopharmaceutical Sales Volume by Application (2026-2031) & (K Dose)

Table 36. Global Radiopharmaceutical Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Radiopharmaceutical Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Radiopharmaceutical Price by Application (2020-2025) & (USD/Dose)

Table 39. Global Radiopharmaceutical Price by Application (2026-2031) & (USD/Dose)

Table 40. Global Radiopharmaceutical Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Radiopharmaceutical Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Radiopharmaceutical Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Radiopharmaceutical Sales Value by Region (2020-2025) & (%)

Table 44. Global Radiopharmaceutical Sales Value by Region (2026-2031) & (%)

Table 45. Global Radiopharmaceutical Sales Volume by Region (K Dose): 2020 VS 2024 VS 2031

Table 46. Global Radiopharmaceutical Sales Volume by Region (2020-2025) & (K Dose)

Table 47. Global Radiopharmaceutical Sales Volume by Region (2026-2031) & (K Dose)

Table 48. Global Radiopharmaceutical Sales Volume by Region (2020-2025) & (%)

Table 49. Global Radiopharmaceutical Sales Volume by Region (2026-2031) & (%)

Table 50. Global Radiopharmaceutical Average Price by Region (2020-2025) & (USD/Dose)

Table 51. Global Radiopharmaceutical Average Price by Region (2026-2031) & (USD/Dose)

Table 52. Key Countries/Regions Radiopharmaceutical Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Radiopharmaceutical Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Radiopharmaceutical Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Radiopharmaceutical Sales Volume, (2020-2025) & (K Dose)

Table 56. Key Countries/Regions Radiopharmaceutical Sales Volume, (2026-2031) & (K Dose)

Table 57. Cardinal Health Company Information

Table 58. Cardinal Health Introduction and Business Overview

Table 59. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 60. Cardinal Health Radiopharmaceutical Product Offerings

Table 61. Cardinal Health Recent Development

Table 62. GE Healthcare Company Information

Table 63. GE Healthcare Introduction and Business Overview

Table 64. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 65. GE Healthcare Radiopharmaceutical Product Offerings

Table 66. GE Healthcare Recent Development

Table 67. Jubilant Pharma Company Information

Table 68. Jubilant Pharma Introduction and Business Overview

Table 69. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 70. Jubilant Pharma Radiopharmaceutical Product Offerings

Table 71. Jubilant Pharma Recent Development

Table 72. Novartis Company Information

Table 73. Novartis Introduction and Business Overview

Table 74. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 75. Novartis Radiopharmaceutical Product Offerings

Table 76. Novartis Recent Development

Table 77. Curium Pharma Company Information

Table 78. Curium Pharma Introduction and Business Overview

Table 79. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 80. Curium Pharma Radiopharmaceutical Product Offerings

Table 81. Curium Pharma Recent Development

Table 82. SIEMENS Company Information

Table 83. SIEMENS Introduction and Business Overview

Table 84. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 85. SIEMENS Radiopharmaceutical Product Offerings

Table 86. SIEMENS Recent Development

Table 87. Lantheus Company Information

Table 88. Lantheus Introduction and Business Overview

Table 89. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 90. Lantheus Radiopharmaceutical Product Offerings

Table 91. Lantheus Recent Development

Table 92. Bracco Imaging Company Information

Table 93. Bracco Imaging Introduction and Business Overview

Table 94. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 95. Bracco Imaging Radiopharmaceutical Product Offerings

Table 96. Bracco Imaging Recent Development

Table 97. Bayer Company Information

Table 98. Bayer Introduction and Business Overview

Table 99. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 100. Bayer Radiopharmaceutical Product Offerings

Table 101. Bayer Recent Development

Table 102. Eli Lilly Company Information

Table 103. Eli Lilly Introduction and Business Overview

Table 104. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 105. Eli Lilly Radiopharmaceutical Product Offerings

Table 106. Eli Lilly Recent Development

Table 107. Aurobindo Pharma Company Information

Table 108. Aurobindo Pharma Introduction and Business Overview

Table 109. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 110. Aurobindo Pharma Radiopharmaceutical Product Offerings

Table 111. Aurobindo Pharma Recent Development

Table 112. Mundipharma Company Information

Table 113. Mundipharma Introduction and Business Overview

Table 114. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 115. Mundipharma Radiopharmaceutical Product Offerings

Table 116. Mundipharma Recent Development

Table 117. China Isotope & Radiation Company Information

Table 118. China Isotope & Radiation Introduction and Business Overview

Table 119. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 120. China Isotope & Radiation Radiopharmaceutical Product Offerings

Table 121. China Isotope & Radiation Recent Development

Table 122. Dongcheng Company Information

Table 123. Dongcheng Introduction and Business Overview

Table 124. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 125. Dongcheng Radiopharmaceutical Product Offerings

Table 126. Dongcheng Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Radiopharmaceutical Downstream Customers

Table 130. Radiopharmaceutical Distributors List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Radiopharmaceutical Product Picture

Figure 2. Global Radiopharmaceutical Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Radiopharmaceutical Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Radiopharmaceutical Sales Volume (2020-2031) & (K Dose)

Figure 5. Global Radiopharmaceutical Sales Price (2020-2031) & (USD/Dose)

Figure 6. Radiopharmaceutical Report Years Considered

Figure 7. Global Radiopharmaceutical Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Radiopharmaceutical Players Sales Volume Ranking (2024) & (K Dose)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Revenue in 2024

Figure 10. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Diagnostic Radiopharmaceuticals Picture

Figure 12. Therapeutic Radiopharmaceuticals Picture

Figure 13. Global Radiopharmaceutical Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Radiopharmaceutical Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Radiopharmaceutical Sales Volume by Type (2020 VS 2024 VS 2031) & (K Dose)

Figure 16. Global Radiopharmaceutical Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Radiopharmaceutical Price by Type (2020-2031) & (USD/Dose)

Figure 18. Product Picture of Oncology

Figure 19. Product Picture of Cardiology

Figure 20. Product Picture of Other

Figure 21. Global Radiopharmaceutical Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Radiopharmaceutical Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Radiopharmaceutical Sales Volume by Application (2020 VS 2024 VS 2031) & (K Dose)

Figure 24. Global Radiopharmaceutical Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Radiopharmaceutical Price by Application (2020-2031) & (USD/Dose)

Figure 26. North America Radiopharmaceutical Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Radiopharmaceutical Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Radiopharmaceutical Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Radiopharmaceutical Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Radiopharmaceutical Sales Volume (%), (2020-2031)

Figure 38. United States Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 44. China Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 46. China Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 56. India Radiopharmaceutical Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Radiopharmaceutical Sales Value by Type (%), 2024 VS 2031

Figure 58. India Radiopharmaceutical Sales Value by Application (%), 2024 VS 2031

Figure 59. Radiopharmaceutical Industrial Chain

Figure 60. Radiopharmaceutical Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Nuclear Medicine Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Global SPECT Radiopharmaceuticals Market Research Report 2025

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Global Targeted Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceutical Injector Market Research Report 2025

Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030

Global Radioisotopes in Medicine Market Research Report 2025

Global Medical Radioisotopes Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions